Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2010-01-21 Audit Report / Informat…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Audit Report / Information 2009
Audit Report / Information Classification · 98% confidence The document is titled "KONCERNREGNSKAB FOR 2009" (Group Financial Statements for 2009) and is dated January 21, 2010. It contains detailed financial performance metrics for the full year 2009 (sales, gross margin, operating profit, net income, ROIC) and provides outlook/expectations for 2010. The document structure, including key figures tables and segment analysis, is characteristic of a comprehensive annual financial report. Although the text is in Danish, the content clearly aligns with the definition of an Annual Report (10-K equivalent for non-US filers, or a comprehensive annual filing). The document length (75,664 chars) confirms it is a substantial report, not just a brief announcement (ruling #2 does not apply). Therefore, it is classified as an Annual Report. FY 2009
2010-01-21 English
Director's Dealing 2009
Director's Dealing Classification · 99% confidence The document explicitly details 'TRADING BY MANAGEMENT' (specifically an 'Employee representative of BoD') involving the purchase and sale of company shares via 'Share options' on specific dates. This directly aligns with the definition of reporting personal share transactions by company directors and executives, which corresponds to the Director's Dealing category (DIRS). The document is a formal announcement of insider transactions.
2009-12-07 English
Regulatory Filings 2009
Regulatory Filings
2009-12-07 Danish
Regulatory Filings 2009
Regulatory Filings
2009-11-25 Danish
Director's Dealing 2009
Director's Dealing Classification · 99% confidence The document explicitly details transactions made by management (President & CEO) in the company's shares, referencing the trading date, number of shares traded, and market value. This directly aligns with the definition of Director's Dealing (insider trades by executives). The title 'TRADING BY MANAGEMENT' and the content structure confirm this classification. This corresponds to code DIRS.
2009-11-25 English
Regulatory Filings 2009
Regulatory Filings
2009-11-24 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.